Published in Ann Surg on June 01, 2005
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg (2007) 2.12
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant (2010) 1.93
Analysis of adult 20-year survivors after liver transplantation. Hepatol Int (2014) 1.45
Impact of broader sharing on the transport time for deceased donor livers. Liver Transpl (2014) 1.41
Low-volume deceased donor liver transplantation alongside a strong living donor liver transplantation service. World J Surg (2014) 1.40
Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg (2006) 1.20
Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases. Ann Surg (2007) 1.15
Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg (2006) 1.06
Biliary complications after a right-lobe living donor liver transplantation. J Gastroenterol (2005) 0.99
Pediatric liver transplantation. World J Gastroenterol (2009) 0.92
Life expectancy of adult liver allograft recipients in the UK. Gut (2006) 0.91
Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors. HPB (Oxford) (2014) 0.88
Biliary complications in liver transplantation. Hepatol Int (2008) 0.87
Native macrophages genetically modified to express heme oxygenase 1 protect rat liver transplants from ischemia/reperfusion injury. Liver Transpl (2011) 0.85
Futility and rationing in liver retransplantation: when and how can we say no? J Hepatol (2012) 0.81
Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation. BMC Cancer (2011) 0.81
Current diagnosis and treatment of benign biliary strictures after living donor liver transplantation. World J Gastroenterol (2016) 0.81
Liver retransplantation in adults: a single-centre, 25-year experience. HPB (Oxford) (2010) 0.80
Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era. Ann Transplant (2014) 0.80
Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Ann Surg (2006) 0.80
Long-term results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years. World J Surg (2013) 0.80
Treatment of Hepatitis C Virus Infection in Liver Transplant Recipients. Gastroenterol Hepatol (N Y) (2016) 0.80
Endoscopic stent placement above the intact sphincter of Oddi for biliary strictures after living donor liver transplantation. J Gastroenterol (2013) 0.79
Historical perspective of living donor liver transplantation. World J Gastroenterol (2008) 0.79
Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat. PLoS One (2012) 0.78
Impact of MELD allocation policy on survival outcomes after liver transplantation: a single-center study in northeast Brazil. Clinics (Sao Paulo) (2011) 0.77
Impact of early biliary complications in liver transplantation in the presence or absence of a T-tube: a Chinese transplant centre experience. Postgrad Med J (2007) 0.77
Liver transplantation(). J Ultrasound (2007) 0.77
Celsior versus University of Wisconsin preserving solutions for liver transplantation: postreperfusion syndrome and outcome of a 5-year prospective randomized controlled study. World J Surg (2011) 0.77
Liver grafts from selected older donors do not have significantly more ischaemia reperfusion injury. HPB (Oxford) (2011) 0.77
Evaluation of cytomegalovirus infection after six months of liver transplantation in children in shiraz, southern iran. Int J Organ Transplant Med (2011) 0.76
Liver transplantation in Greek children: 15 years experience. Pediatr Rep (2010) 0.75
Corticosteroid-free immunosuppression in liver transplantation: an evidence-based review. World J Gastroenterol (2014) 0.75
Evaluating twenty-years of follow-up after orthotopic liver transplantation, best practice for donor-recipient matching: What can we learn from the past era? World J Transplant (2016) 0.75
Evaluation of Candida infection after six months of transplantation in pediatric liver recipients in iran. Int J Organ Transplant Med (2011) 0.75
Management issues in post living donor liver transplant biliary strictures. World J Hepatol (2016) 0.75
Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant. Mayo Clin Proc (2010) 0.75
Liver retransplantation for adult recipients. Korean J Hepatobiliary Pancreat Surg (2013) 0.75
Identifying independent risk factors for graft loss after primary liver transplantation. Langenbecks Arch Surg (2017) 0.75
Impact of comorbidity on waiting list and post-transplant outcomes in patients undergoing liver retransplantation. World J Hepatol (2017) 0.75
Evolution of liver transplantation. Hepatology (1982) 19.54
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. Surg Gynecol Obstet (1963) 10.22
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med (1994) 4.22
Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med (1996) 4.10
MELD and PELD: application of survival models to liver allocation. Liver Transpl (2001) 3.76
Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl (2002) 2.98
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91
Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology (1994) 2.73
National Institutes of Health Consensus Development Conference Statement: liver transplantation--June 20-23, 1983. Hepatology (1984) 2.50
The utility of marginal donors in liver transplantation. Liver Transpl (2003) 2.49
Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl (2004) 2.31
Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl (2002) 2.03
Long-term survival after retransplantation of the liver. Ann Surg (1997) 1.91
Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol (1997) 1.91
The first 100 liver transplants at UCLA. Ann Surg (1987) 1.84
The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81
A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg (2001) 1.73
Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1999) 1.63
Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg (1987) 1.54
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology (1998) 1.48
Organ Procurement and Transplantation Network--HRSA. Final rule with comment period. Fed Regist (1998) 1.45
Liver transplantation today. Ann Intern Med (1986) 1.34
Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet (1995) 1.24
Hepatic Retransplantation--an analysis of risk factors associated with outcome. Transplantation (1996) 1.22
Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg (2002) 1.22
Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg (2000) 1.21
Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? Transplantation (1994) 1.18
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transpl (2004) 1.12
One hundred in situ split-liver transplantations: a single-center experience. Ann Surg (2003) 1.11
Orthotopic liver allotransplantation using an internal vascular shunt. Surg Gynecol Obstet (1968) 1.03
A simple model to estimate survival after retransplantation of the liver. Transplantation (1999) 1.02
Operations upon the biliary tract during transplantation of the liver. Surg Gynecol Obstet (1987) 0.99
Liver transplantation at UCLA. Program development, organization, initiation, and early results. Am J Surg (1986) 0.96
Branch patch for arterialization of hepatic grafts. Surg Gynecol Obstet (1986) 0.94
Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl (2003) 0.92
New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann Surg (2002) 0.91
FK 506 rescue therapy in liver transplantation: outcome and complications. Transplant Proc (1991) 0.89
A prospective study on the use of monoclonal anti-T3-cell antibody (OKT3) to treat steroid-resistant liver transplant rejection. Arch Surg (1987) 0.88
Early graft function after pediatric liver transplantation: comparison between in situ split liver grafts and living-related liver grafts. Transplantation (2001) 0.88
Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation. Transplantation (1989) 0.87
Retransplantation for recurrent hepatitis C. Liver Transpl (2002) 0.87
The Cambridge and King's College Hospital experience of liver transplantation, 1968-1983. Hepatology (1984) 0.86
Celiac compression syndrome and liver transplantation. Ann Surg (1993) 0.85
Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejection. Transplantation (1995) 0.84
Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seropositive donors. Transplantation (1997) 0.81
Treatment of recurrent hepatitis C. Liver Transpl (2002) 0.79
Retransplantation for recurrent hepatitis C in the model for end-stage liver disease era: how should we or shouldn't we? Liver Transpl (2003) 0.78
Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med (2006) 4.31
The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl (2002) 3.44
Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int (2011) 3.36
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res (2011) 2.99
Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl (2002) 2.98
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. Am J Gastroenterol (2010) 2.63
Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl (2005) 2.63
Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62
Selective use of computed tomography compared with routine whole body imaging in patients with blunt trauma. Ann Emerg Med (2011) 2.45
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol (2011) 2.40
Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2008) 2.30
Incisional hernia after liver transplantation. J Am Coll Surg (2006) 2.23
An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol (2010) 2.18
Telephone intervention with family caregivers of stroke survivors after rehabilitation. Stroke (2002) 2.18
Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg (2009) 2.16
Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients. J Manag Care Pharm (2008) 2.16
Ammonia levels and the severity of hepatic encephalopathy. Am J Med (2003) 2.14
Liver transplantation in highest acuity recipients: identifying factors to avoid futility. Ann Surg (2014) 2.13
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. Transplantation (2015) 2.13
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg (2007) 2.12
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B. Gastroenterology (2005) 2.08
Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol (2009) 1.97
Health-related quality of life and family function following pediatric liver transplantation. Liver Transpl (2008) 1.90
Characteristics of highly ranked applicants to general surgery residency programs. JAMA Surg (2013) 1.81
Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology (2004) 1.80
Is the use of pan-computed tomography for blunt trauma justified? A prospective evaluation. J Trauma (2009) 1.79
MELD fails to measure quality of life in liver transplant candidates. Liver Transpl (2005) 1.79
Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transpl (2005) 1.76
Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol (2006) 1.73
Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl (2003) 1.71
Outcome of liver transplantation in septuagenarians: a single-center experience. Arch Surg (2007) 1.69
Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology (2005) 1.66
Aggressive resection of hepatocellular carcinoma with right atrial involvement. Am Surg (2009) 1.66
Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video). Gastrointest Endosc (2010) 1.65
Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg (2008) 1.65
Chronic viral hepatitis and hepatocellular carcinoma. World J Surg (2007) 1.62
Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med (2008) 1.61
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl (2007) 1.58
Operative parameters that predict the outcomes of hepatic transplantation. J Am Coll Surg (2003) 1.58
Laparoscopic surgery for cancer: a systematic review and a way forward. J Am Coll Surg (2010) 1.58
Giant cavernous liver hemangiomas: effect of operative approach on outcome. Arch Surg (2004) 1.58
Risk factors for recurrence after repair of enterocutaneous fistula. Arch Surg (2009) 1.57
Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg (2007) 1.57
Serum ferritin concentration predicts mortality in patients awaiting liver transplantation. Hepatology (2010) 1.56
Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg (2012) 1.55
A caspase inhibitor, IDN-6556, ameliorates early hepatic injury in an ex vivo rat model of warm and cold ischemia. Liver Transpl (2007) 1.53
Treating hepatitis C in the prison population is cost-saving. Hepatology (2008) 1.50
Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg (2011) 1.50
Service or education: in the eye of the beholder. Arch Surg (2011) 1.49
MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl (2003) 1.49
Outcomes of acute rejection after interferon therapy in liver transplant recipients. Liver Transpl (2004) 1.47
Together, Rpn10 and Dsk2 can serve as a polyubiquitin chain-length sensor. Mol Cell (2009) 1.47